New opioid recommendations: Pain from most dermatologic procedures should be managed with acetaminophen, ibuprofen
Just 21 of 87 procedures might require a limited opioid prescription at discharge.
NATIONAL HARBOR, MD. – In a phase 1/2 trial of previously untreated advanced melanoma patients, the combination of bempegaldesleukin and nivolumab...
Pfizer said that current plans are to launch the drug in the United States in 2023.
Topics in this guideline for pediatric psoriasis include systemic and topical treatments, management of comorbidities, and quality of life.
LAS VEGAS –Targeted screening efforts that stratify by risk factors and by age “makes screening more efficient and more cost effective.”
This is the first treatment approved to help patients with erythropoietic protoporphyria increase their exposure to light.
The approval is based on results from a pair of randomized, double-blind, placebo-controlled, phase 3 studies involving 657 adult patients with...
Translating the 2019 AAD-NPF Guidelines of Care for the Management of Psoriasis With Biologics to Clinical Practice
In February 2019, the American Academy of Dermatology (AAD) and the National Psoriasis Foundation (NPF) released a novel set of guidelines...
SEATTLE – Culture draws were associated with a 20% increase in hospital length of stay.